Efficacy and safety of tranexamic acid in intracranial haemorrhage: A meta-analysis.
PLoS ONE · 2023-01-01 · Meta-analysis
Abstract
BACKGROUND: Although some studies have shown that tranexamic acid is beneficial to patients with intracranial haemorrhage, the efficacy and safety of tranexamic acid for intracranial haemorrhage remain controversial. METHOD: The PubMed, EMBASE, and Cochrane Library databases were systematically searched. The review followed PRISMA guidelines. Data were analyzed using the random-effects model. RESULTS: Twenty-five randomized controlled trials were included. Tranexamic acid significantly inhibited hematoma growth in intracranial hemorrhage (ICH) and traumatic brain injury (TBI) patients. (ICH: mean difference -1.76, 95%CI -2.78 to -0.79, I2 = 0%, P < .001; TBI: MD -4.82, 95%CI -8.06 to -1.58, I2 = 0%, P = .004). For subarachnoid hemorrhage (SAH) patients, it significantly decreased the risk of hydrocephalus (OR 1.23, 95%CI 1.01 to 1.50, I2 = 0%, P = .04) and rebleeding (OR, 0.52, 95%CI 0.35 to 0.79, I2 = 56% P = .002). There was no significance in modified Rankin Scale, Glasgow Outcome Scale 3-5, mortality, deep vein thrombosis, pulmonary embolism, or ischemic stroke/transient ischemic. CONCLUSION: Tranexamic acid can significantly reduce the risk of intracranial haemorrhage growth in patients with ICH and TBI. Tranexamic acid can reduce the incidence of complications (hydrocephalus, rebleeding) in patients with SAH, which can indirectly improve the quality of life of patients with intracranial haemorrhage.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Haemostatics · Mortality & survival · Quality of life & function · Tranexamic acid
Related articles
- Tranexamic acid for neurological outcomes and mortality in adults with hemorrhagic acute brain injury: an updated systematic review and meta-analysis of randomized controlled trials. (Front Neurol, 2026)
- Comparative effectiveness and safety of pharmacological interventions for secondary brain injury in adult traumatic brain injury: a network meta-analysis of randomized trials. (BMC Neurol, 2026)
- Tranexamic acid in the management of traumatic brain injury: a systematic review and meta-analysis with trial sequential analysis. (Einstein (Sao Paulo), 2025)
- Efficacy and safety of tranexamic acid in acute traumatic brain injury: A meta-analysis of randomized controlled trials. (Am J Emerg Med, 2024)
- Tranexamic acid in patients with traumatic brain injury: a meta-analysis. (Rev Esp Anestesiol Reanim (Engl Ed), 2024)
- Place of tranexamic acid in traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials (Disaster and Emergency Medicine Journal, 2021)